New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Shape
Vivos Therapeutics, Inc.
VVOS
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

26M

Medical - Devices

Next Earning date - 26 Mar 2025

26M

Medical - Devices

Next Earning date - 26 Mar 2025

4.37USD
Shape0.12 ( 2.82%)
Market Closed (as of Jan 03, 21:00 EDT)
favorite-chart

Relative Strenght

92
favorite-chart

Volume Buzz

14%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

56%

Quote Panel

Shape
Updated January 4, 2025
1W -1.58 % 1M 8.98 % 3M 80.58 % 1Y -53.16 %

Key Metrics

Shape
  • Market Cap

    25.74M


  • Shares Outstanding

    5.89M


  • Share in Float

    4.67M


  • Dividende

    0


  • Earning Date

    26 Mar 2025


  • Price Target

    4.37


  • Average Volume

    192120


  • Beta

    7.678


  • Range

    1.91-9.99


  • Industry

    Medical - Devices


  • Website

    https://vivos.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.77x

P/S Ratio

3.77x

P/B Ratio

0.0

Debt/Equity

-86.2%

Net Margin

$-5.0

EPS

How VVOS compares to sector?

P/E Ratio

Relative Strength

Shape

VVOS

Sector

90 days

Showing graph for last 90 days.

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Scholar Rock Holding Corporation

99

2.68%

Tevogen Bio Holdings Inc.

98

10.89%

Summit Therapeutics Inc.

98

1.96%

NewAmsterdam Pharma Company N.V.

98

1.58%

Anavex Life Sciences Corp.

97

3.69%

Forecast

Shape

$19M

Shape396%

2025-Revenue

$1.06

Shape-166%

2025-EPS

$18M

Shape-625%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-5.00
vs -22.00

Q1.23

arrow
arrow

N/A

NA
vs -6.50

Q2.23

arrow
arrow

N/A

-3.75
vs -8.27

Q3.23

arrow
arrow

N/A

-1.75
vs -8.25

Q4.23

arrow
arrow

N/A

-3.05
vs -5.00

Q1.24

arrow
arrow

N/A

-1.63
vs NA

Q2.24

arrow
arrow

N/A

-0.60
vs -3.75

Q3.24

arrow
arrow

+100%

NA
vs -1.75

Q4.24

arrow
arrow

N/A

-0.40
vs -3.05

Q1.25

arrow
arrow

N/A

-0.41
vs -1.63

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-10%

4M  vs 4.4M

Q1.23

arrow
arrow

+11%

3.9M  vs 3.5M

Q2.23

arrow
arrow

-19%

3.4M  vs 4.2M

Q3.23

arrow
arrow

-22%

3.3M  vs 4.2M

Q4.23

arrow
arrow

-18%

3.2M  vs 4M

Q1.24

arrow
arrow

-11%

3.4M  vs 3.9M

Q2.24

arrow
arrow

+19%

4.1M  vs 3.4M

Q3.24

arrow
arrow

+17%

3.9M  vs 3.3M

Q4.24

arrow
arrow

+20%

3.9M  vs 3.2M

Q1.25

arrow
arrow

+20%

4.1M  vs 3.4M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-152%

-1.52
vs -0.55

Q1.23

arrow
arrow

+68%

0.68
vs -1.52

Q2.23

arrow
arrow

-262%

-2.62
vs 0.68

Q3.23

arrow
arrow

-4550%

-45.50
vs -2.62

Q4.23

arrow
arrow

-1036%

-10.36
vs -45.50

Q1.24

arrow
arrow

-647%

-6.47
vs -10.36

Q2.24

arrow
arrow

-30%

-0.30
vs -6.47

Q3.24

arrow
arrow

-34%

-0.34
vs -0.30

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

29

29
vs 29

NA

Q2.22

arrow
arrow

25

25
vs 29

-14%

Q3.22

arrow
arrow

27

27
vs 25

8%

Q4.22

arrow
arrow

27

27
vs 27

NA

Q1.23

arrow
arrow

31

31
vs 27

15%

Q2.23

arrow
arrow

30

30
vs 31

-3%

Q3.23

arrow
arrow

26

26
vs 30

-13%

Q4.23

arrow
arrow

1

1
vs 26

-96%

Earnings Growth

Latest News

VVOS

proactiveinvestors.com

9 hours ago